Moderator: Anne Li

Counsel, Crowell & Moring LLP

Anne Elise Herold Li is an intellectual property attorney in the New York office of Crowell & Moring. As a counsel in the Intellectual Property Group, Anne focuses her practice on patent, trademark, and trade secret litigation, counseling, patent procurement, freedom-to-operate, and due diligence. She represents a wide-range of clients, including biotechnology, biopharmaceutical, generic pharmaceutical, medical device, software, and mobile devices, varying from large corporations to start-ups. She litigates in both federal and state court, has been lead counsel in Inter Partes Review (IPR) proceedings, and has also successfully represented clients at the International Trade Commission (ITC). Her practice covers an array of technologies, with a special emphasis on biotechnology, Hatch-Waxman, medical device, and hand-held electronics industries. Her experience includes patent litigation, trade secret misappropriation, trademark enforcement, false advertising, and unfair competition cases. Anne was recognized as a “Rising Star” in intellectual property litigation by Super Lawyers Magazine, New York Metro edition for 2013-2017. Anne handles all aspects of intellectual property litigation, from pre-suit investigations, through discovery, Markman proceedings, summary judgment motions, trials, and appeals. Her experience also includes assisting clients with the evaluation of patents of third parties and rendering detailed opinions relating to patent invalidity, non-infringement, and unenforceability. She advises clients concerning intellectual property procurement and enforcement strategies. Anne is experienced in technology transfer agreements, such as drafting licenses and advising start-up clients on all aspects of intellectual property.

E5: Making Your IP Department into a Value Driver & Corporate Partner

America’s Cup C/D

In today’s world, intellectual property is the lifeblood of value creation in the corporate setting. But, often corporate intellectual property departments are treated as just patent generation machines, with little input into the strategy of the corporation. This approach does not capitalize on the expertise and agility of an intellectual property department to achieve business […]